Atlas Trials

Tolerability of Lopinavir Versus Dolutegravir for Children and Adolescents Living With HIV

Clinical trial NCT05426421 · COMPLETED

Trial details

NCT number
NCT05426421
Sponsor
Swiss Tropical & Public Health Institute
Status
COMPLETED
Study type
OBSERVATIONAL
HIV
Start date
2022-07-11
Primary completion
2023-09-20
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.